Onno van de Stolpe
CEO, Galapagos

Hans Schikan
Biotech entrepreneur, Board member, Chair Various biotech companies & organisations

Martine van Vugt
Chief of Staff, Genmab

Tim Knotnerus
CEO, AgomAb Therapeutics N.V.

André van de Sande
Interim Executive, Business Coach, Board Member

Hans Preusting
CEO, Synerkine Pharma

Eric Claassen
Professor of Entrepreneurship in Life SciencesVrije Universiteit Athena Institute

Erik van den Berg
CEO, AM-PharmaCo-founder & Chairman, Lava Therapeutics

Andrej Michalík
European Patent Attorney, Partner De Clercq & Partners 

Florence Verhoestraete
Partner, NautaDutilh

Peter Craddock
Counsel, NautaDutilh

Shelley Margetson
CEO, OCTIMET Oncology NV

Wim Van Camp
General Manager Technology Transfer Ghent University

Tom Liessens
Legal Counsel, Trademark and Design AttorneyDe Clercq & Partners

Dr. Ann De Clercq
Founding Partner & European and Belgian Patent Attorney De Clercq & Partners

Rob Kieboom
Director, Rob Kieboom Training & Consultancy

Eline van Beest-Vrijland
Venture Partner Thuja Capital & Partner Blue Sparrows MedTech Fund & CEO, Hybridize Therapeutics

Jan Kooiman
Adj. Professor of Finance, Business and Accounting, Leiden University

Andre Hoekema
CBO, Galapagos

Simone Botti
Junior Partner, INKEF Capital B.V.

Dries Fransen van de Putte
Attorney-at-law, Loyens & Loeff

Linda van de Burgwal
Assistant Professor, VU Amsterdam